drugset / Trial / NCT05220878
Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP
RandomizedParallel-groupDouble-blindTreatment
Summary
It is a phase III multicenter randomized double-blinded comparative study of clinical efficacy and safety of GNR-069 and Nplate in patients with idiopathic thrombocytopenic purpura
Timeline
- Start
- 2021-09-09
- Primary completion
- 2023-08-22
- Completion
- 2023-10-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GNR-069 | Protein / enzyme biologic | 1 ug/kg | Subcutaneous |
| Comparator | Romiplostim | Peptide | 1 ug/kg | Subcutaneous |